Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Summary

This study evaluates the use of ABI-1968, a topical cream, in the treatment of anal precancerous lesions in adults with and without human immunodeficiency virus (HIV) infection

Timeline

Start

2018-12-17

Primary completion

2019-06-30

Completion

2019-06-30

Outcome

Outcome not reported

Stopped: “Pre-Clinical Toxicology Findings”

Drugs

Indications